Cargando…

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Detalles Bibliográficos
Autores principales:	Dabbous, Hany M., El‑Sayed, Manal H., El Assal, Gihan, Elghazaly, Hesham, Ebeid, Fatma F. S., Sherief, Ahmed F., Elgaafary, Maha, Fawzy, Ehab, Hassany, Sahar M., Riad, Ahmed R., TagelDin, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Retraction Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462367/ https://www.ncbi.nlm.nih.gov/pubmed/34537808 http://dx.doi.org/10.1038/s41598-021-98683-5

Ejemplares similares

RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine: Various toxicities: 7 case reports
Publicado: (2022)

Spectrophotometric determination of favipiravir in presence of its acid hydrolysis product
por: Sharaf, Yasmine Ahmed, et al.
Publicado: (2023)

Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study
por: Alotaibi, Musim, et al.
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations
por: Parlak, Cemal, et al.
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir
por: Alosaimi, Bandar, et al.
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers
por: Turan, Derya Bayırlı, et al.
Publicado: (2022)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Synergetic effect of green synthesized reduced graphene oxide and nano-zero valent iron composite for the removal of doxycycline antibiotic from water
por: Abdelfatah, Ahmed M., et al.
Publicado: (2022)

Analytical Performance and Greenness Evaluation of Five Multi-Level Design Models Utilized for Impurity Profiling of Favipiravir, a Promising COVID-19 Antiviral Drug
por: Ibrahim, Adel Ehab, et al.
Publicado: (2022)

Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen
por: Sharaf, Yasmine Ahmed, et al.
Publicado: (2022)

Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.
por: El-Meteini, Mahmoud, et al.
Publicado: (2014)

A highly sensitive and green electroanalytical method for the determination of favipiravir in pharmaceutical and biological fluids
por: El-Sayed, Heba M., et al.
Publicado: (2023)

Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA
por: Delen, Leman Acun, et al.
Publicado: (2022)

Efficient Removal of Phosphate from Wastewater by a Novel Phyto-Graphene Composite Derived from Palm Byproducts
por: El-Maghrabi, Nourhan, et al.
Publicado: (2022)

A solvent-free HPLC method for the simultaneous determination of Favipiravir and its hydrolytic degradation product
por: Sharaf, Yasmine Ahmed, et al.
Publicado: (2023)

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

Evaluation of esthetic outcome of delayed implants with de-epithelialized free gingival graft in thin gingival phenotype with or without immediate temporization: a randomized clinical trial
por: Fawzy, Maha, et al.
Publicado: (2023)

SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Conventional and synchronous spectrofluorometric determination of the recently administered drugs for treatment of COVID-19 favipiravir and apixaban
por: Elama, Heba Samir, et al.
Publicado: (2022)

An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19
por: Ali, Marwa F. B., et al.
Publicado: (2023)

Eco-friendly spectrophotometric methods for determination of remdesivir and favipiravir; the recently approved antivirals for COVID-19 treatment
por: Elama, Heba Samir, et al.
Publicado: (2023)

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
por: Kaptein, Suzanne J. F., et al.
Publicado: (2020)

Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
por: Surabotsophon, Manoon, et al.
Publicado: (2020)

Biogenic synthesis of reduced graphene oxide from Ziziphus spina-christi (Christ’s thorn jujube) extracts for catalytic, antimicrobial, and antioxidant potentialities
por: Mahmoud, Alaa El Din, et al.
Publicado: (2022)

Development of a liquid phase radioimmunoassay for the measurement of serum ferritin levels for the detection of Covid-19 in patients
por: Riad, Emil Michael, et al.
Publicado: (2022)

The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC–MS characterization, and In-vitro safety evaluation
por: Abdallah, Inas A., et al.
Publicado: (2022)

Impact of biliary complications on quality of life in live-donor liver transplant recipients
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021)

Biliary complications in recipients of living donor liver transplantation: A single-centre study
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021)

Synthesis of β-Enaminonitrile-Linked 8-Methoxy-1H-Benzo[f]Chromene Moieties and Analysis of Their Antitumor Mechanisms
por: Elgaafary, Menna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvv464peiut0t8p5k11sbne1qi